Investing in biotech and pharma stocks is certainly not for everyone, as these companies are vulnerable to various external risks. I turned bullish on Pfizer last January based on several reasons, ...

(WXMI) — The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have identified a potential safety concern for ischemic stroke in people ages 65 and older who ...

In a world of wild talk and fake news, help us stand up for the facts.

Vaxcyte unveiled what analysts called “stunning” phase 1/2 data for its 31-valent pneumococcal vaccine candidate that, if replicated in a large pivotal study, could pose a serious threat to Pfizer’s ...

WASHINGTON — The release of COVID-19 vaccine results after the 2020 election may have not been a “coincidence” — and could have been part of an effort by senior Pfizer executives to “deliberately slow ...

The JN.1 Novavax vaccine is an alternative to the LP.8.1 Pfizer-BioNTech and Moderna vaccines that were rolled out in October ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (The Hill) — Pfizer’s COVID-19 vaccine was ...

Pfizer is implementing a “cost realignment program” expected to save the pharmaceutical giant at least $3.5 billion as it prepares for revenue drops for its Covid-19 vaccine and Paxlovid, a ...

Pfizer and BioNTech’s combination flu and COVID-19 vaccine resulted in a robust immune response in a Phase 1/2 study, the companies announced Thursday. The release of the topline data trailed just a ...

NEW YORK (WABC) -- Pfizer/BioNTech plans to ask for authorization of a COVID-19 vaccine for some children under 12 soon, bringing the US one step closer to offering protection to a population that has ...

Chiefs tight end Travis Kelce in commercial for Pfizer. Have you heard the news about Travis Kelce? No, not that news. The Kansas City Chiefs tight end — a two-time Super Bowl winner, multiple-time ...